Click to view our accessibility statement or contact us with accessibility-related questions


What We Do

We are a global bioscience company dedicated to healthy aging. Our team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. We are the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by our patent portfolio.


We deliver Niagen® as the sole active ingredient in our consumer product Tru Niagen®.

We also have a business unit focused on natural product fine chemicals (known as “phytochemicals”).

ChromaDex, Inc. is listed on NASDAQ, stock name CDXC.


ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of nicotinamide adenine dinucleotide (“NAD”) and to identify and develop novel, science-based ingredients.

The ChromaDex laboratory is accredited to ISO/IEC 17025:2017 meaning that the laboratory meets the program requirements in the field of chemical testing. The accreditation demonstrates technical competence for the scope defined in the link below and the operation of a laboratory quality management system. Additionally, ChromaDex is a reference material producer accredited to ISO 17034:2016 covering the specific materials listed in the scope found in the other link below.

A2LA Accredited Symbol 5211.01   A2LA accredited symbol 5211.02

Our Culture

At ChromaDex, we foster a culture of empowerment, ownership and trust. Our incredible employees achieve success by acting with integrity, transparency and excitement. We firmly believe that through innovation, science and collaboration between our teams, we can aim to improve global health and ultimately impact the quality of all human lives. 

We are constantly looking for new team members who share our passion for our mission and want to be part of our story.